Zaki H S, Jenkinson M D, Du Plessis D G, Smith T, Rainov N G
Department of Neurosurgery, The Walton Centre for Neurology and Neurosurgery NHS Trust, Liverpool, UK.
Acta Neurochir (Wien). 2004 Aug;146(8):841-5. doi: 10.1007/s00701-004-0282-8. Epub 2004 Jun 7.
Malignant gliomas of the brain typically exhibit on CT or MRI a strong peripheral contrast enhancement area with a variable central zone of necrosis. These tumours are not known to change their radiological appearance and contrast enhancement pattern under systemic steroid treatment--a feature usually associated with primary CNS lymphoma. We report two cases of adult patients with glioblastoma multiforme and atypical hemispherical contrast enhancement initially demonstrated on MRI or CT, which disappeared after dexamethasone administration. At the same time, however, another tumour focus became visible, in both cases localised in the corpus callosum. Histological diagnosis was confirmed by stereotactic biopsy in both cases. This unusual changing pattern of contrast enhancement seems to be associated with multifocal malignant glioma with partial blood-brain barrier disruption modified by dexamethasone, and may present diagnostic difficulties in respect to neuroimaging and selection of target areas for tumour biopsy.
脑恶性胶质瘤在CT或MRI上通常表现为周边有明显的对比增强区,中央有不同程度的坏死区。已知这些肿瘤在全身类固醇治疗下不会改变其放射学表现和对比增强模式,而这一特征通常与原发性中枢神经系统淋巴瘤相关。我们报告了两例成年多形性胶质母细胞瘤患者,最初在MRI或CT上显示为非典型半球形对比增强,在给予地塞米松后消失。然而,与此同时,在两例患者中均可见另一个肿瘤灶,均位于胼胝体。两例均经立体定向活检确诊组织学诊断。这种不寻常的对比增强变化模式似乎与多灶性恶性胶质瘤有关,其血脑屏障部分破坏被地塞米松改变,这可能在神经影像学诊断及肿瘤活检靶区选择方面带来困难。